Sinus Dynamics Reports Effective Results with the use of Nebulized TOBRAMYCIN in Treating Bacterial Sinusitis

As allergy season arrives, the approximate 37 million Americans who suffer from sinusitis annually, will need a form of relief to stop The Sinusitis before it reaches the point of surgery. Luckily, with advanced technology and Sinus Dynamics, www.sinusdynamics.com uses the latest technology and offers a new way to fight sinus infections using a nebulized TOBRAMYCIN treatment to fight against sinusitis and other sinus related conditions.

Westlake Village, Ca (PRWEB) July 22, 2008 -- As allergy season arrives, the approximate 37 million Americans who suffer from sinusitis annually, will need a form of relief to stop The Sinusitis before it reaches the point of surgery. Luckily, with advanced technology and Sinus Dynamics, www.sinusdynamics.com uses the latest technology and offers a new way to fight sinus infections using a nebulized TOBRAMYCIN treatment to fight against sinusitis and other sinus related conditions.

The TOBRAMYCIN nebulized treatment is delivered through the Sinus Aero Aerosol Medication Delivery System, which is delivered right to the source of the sinusitis. Sinus Dynamics treatment medications are nebulized at 3.2 microns in particle size and have the ability to easily make their way into the sinuses, where the sinusitis actually lies. If you have used oral antibiotics, anti-fungal, or anti-inflammatory to treat sinusitis before, you know that there are usually systemic side effects. However, with this new technology and treatment, antibiotics and other medications are aerosolized and implemented topically in sinuses, which results in little to no side effects since there is such low systematic absorption. The sinus cavities are hollow pockets with very low blood flow through them; therefore oral antibiotics have difficulty getting into the sinuses. However, Sinus Dynamics TOBRAMYCIN nebulized antibiotics are only distributed into the sinuses, which gives a much greater success rate at defeating sinusitis. Sinus surgery is usually an option which is used after all other treatment forms have been exhausted. Sinus Dynamics was recently recognized in the Harvard Medical School Guide to Healing Your Sinuses regarding their successful topical form of treatment. Sinus Dynamics treatment is also supported by several clinical studies.

Sinus Dynamics is an affordable, non-invasive treatment that is simple to use. Treatment with the sinus aero only requires a short inhalation of the medication. Sinus Dynamics handles all patient relations and their prescriptions from the moment that the prescription is received from the physician offices nationwide. They answer any questions or concerns that a patient might have handling insurance details and works with many insurance companies. The Sinus Dynamics program is used mainly by ENT's and Allergists in North America, though any physician may order the treatment for their Sinusitis patients. Select antibiotics, anti-fungal and anti-inflammatory are offered to help relieve patients of their symptoms of sinusitis and allergies. Sinus Dynamics can be visited on the web at www.sinusdynamics.com or reached toll free at 800-996-5210. With Sinus Dynamics aerosolized medication for sinuses, more patients can enjoy a healthier life.*

Deposition of Aerosolized Particles in the Maxillary Sinuses Before and After Endoscopic Sinus Surgery - Michele B. St. Martin, MD, Cory J. Hitzman, B.Ch.E; Timothy S. Wiedmann, Ph.D; and Frank L. Rimell, M.D. American Journal of Rhinology, March-April 2007, Vol. 21, No.2

Effectiveness of topical antibiotics on Staphylococcus aureus bio_lm in vitro - Martin Desrosiers, M.D., Zohra Bendouah, M.Sc., and Jean Barbeau, Ph.D. (Canada) American Journal of Rhinology, March-April 2007, Vol. 21, No. 2
Efficiency of Pulmonary Administration of Tobramycin Solution for Inhalation in Cystic Fibrosis Using and Improved Drug Delivery System - David E. Geller, M.D.; Margaret Rosenfeld, M.D., MPH; David A. Waltz, M.D.; and Robert W. Wilmott, M.D. FCCP; for the AeroDose TOBI Study Group

Budesonide Administration with a Novel Aerosol Generator: An in vitro Evaluation - Fink JB, Simon M, Klimowicz M, Uster PS; Aerogen, Inc., Sunnyvale, CA As presented at American Thoracic Society 97th International Conference, May 2001, San Francisco, California

FOR MORE INFORMATION PLEASE CONTACT US : (800) 996-5210

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1IYWxmLVNpbmctU3F1YS1TaW5nLVNpbmctWmVybw==

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl